Alzheimer. Dementia in Alzheimer's disease
Conditions
Interventions
Intervention 1: First group of intervention: Exelon, Capsule 1.5 mg oral, once daily for 3 months. Intervention 2: Control group: placebo, capsule oral, once daily for 3 months. Intervention 3: Second
Treatment - Drugs
Placebo
First group of intervention: Exelon, Capsule 1.5 mg oral, once daily for 3 months.
Control group: placebo, capsule oral, once daily for 3 months.
Second group of intervention: Piracetam, capsule 800 mg oral, once daily for 3 months.
Third group of intervention: Exelon, Capsule1.5 mg oral, once daily for 3 months and Piracetam, capsule 800 mg oral, once daily for 3 months.
Sponsors
Vice chancellor for research of Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1- age more than 40; 2- diagnosis of Alzheimer disease based on DSM-IV criteria. Exclusion criteria: 1- history of consuming drugs (except for drugs used for controlling hypertension, heart ischemia, hyperlipidemia, diabetes); 2- history of other diseases; 3-Allergy to Piracetam or Rivastigmine.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mini Mental Status Examination. Timepoint: beforthe intervention and 3 months after intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Farhad Iranmanesh
Kerman University of Medical Sciences
Outcome results
None listed